Last reviewed · How we verify
Clinic and neuropsychologic evaluation — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Clinic and neuropsychologic evaluation (Clinic and neuropsychologic evaluation) — Assistance Publique Hopitaux De Marseille.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Clinic and neuropsychologic evaluation TARGET | Clinic and neuropsychologic evaluation | Assistance Publique Hopitaux De Marseille | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Clinic and neuropsychologic evaluation CI watch — RSS
- Clinic and neuropsychologic evaluation CI watch — Atom
- Clinic and neuropsychologic evaluation CI watch — JSON
- Clinic and neuropsychologic evaluation alone — RSS
Cite this brief
Drug Landscape (2026). Clinic and neuropsychologic evaluation — Competitive Intelligence Brief. https://druglandscape.com/ci/clinic-and-neuropsychologic-evaluation. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab